|
시장보고서
상품코드
1807403
세계의 저분자 신약 개발 아웃소싱 시장 : 규모, 점유율 및 동향, 업계 분석(워크플로우별, 서비스별, 최종 용도별, 지역별), 예측(2025-2034년)Small Molecule Drug Discovery Outsourcing Market Size, Share, Trends, Industry Analysis Report By Workflow (Target Identification & Screening, Target Validation & Functional Informatics), By Service, By End Use, By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 분석에 따르면, 세계의 저분자 신약 개발 아웃소싱 시장 규모는 2034년까지 112억 7,000만 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.
저분자 신약 개발 아웃소싱이란 제약기업이나 생명공학기업이 저분자 치료제의 연구개발을 가속 및 최적화하기 위해 전문 개발업무수탁기관(CRO)과 제휴하는 것을 말합니다. 저분자 의약품은 일반적으로 분자량 900 달톤 이하로 생물학적 표적을 조절할 수 있는 화학 합성 화합물로, 암에서 대사성 질환까지 폭넓은 질환의 치료를 제공합니다. 타겟 식별, 히트 투 리드 최적화, 전임상시험, 초기 임상시험 등 신약 개발의 다양한 단계를 아웃소싱함으로써 기업은 외부 전문 지식을 활용하고 비용을 절감하고 일정을 빨리 할 수 있습니다. CRO는 첨단 기술, 높은 처리량 스크리닝, 컴퓨팅 모델링, 의약품 화학에 대한 지원을 제공하여 유망한 의약품 후보를 신속하게 확인할 수 있습니다.
저분자 신약 개발 아웃소싱은 인프라가 제한된 소규모 생명공학 기업과 연구개발비의 합리화를 목표로 하는 주요 제약기업에 특히 가치가 있습니다. 또한 아웃소싱은 다양한 과학적 관점과 인공지능을 활용한 신약 개발 설계와 같은 고급 기술을 통합하여 혁신을 촉진합니다. 신약 개발의 복잡화와 시장 개척 비용의 상승으로 아웃소싱은 전략적으로 필수적이 되어 신약 출시를 향한 효율과 성공률을 높이는 공동 연구가 촉진되고 있습니다.
저분자 신약 개발 아웃소싱 시장 : 분석 개요
워크플로우별로는 제약기업이나 바이오테크놀러지 기업에 의한 R&D 투자 증가로 리드 식별 및 후보 최적화 분야가 2024년의 수익 점유율 33.12%를 차지하고 있습니다.
서비스별로는 히트 투 리드 최적화, 의료 화학, 리드 창출 등 초기 단계의 의약품 개발에 있어서 화학이 하는 중요한 역할에 의해 화학 서비스 분야가 2024년의 매출 점유율을 독점했습니다.
치료 분야별로는 암의 부담 증가와 효과적이고 적대적인 치료에 대한 긴급 수요로부터, 2024년에는 종양 분야가 큰 수익 점유율을 차지했습니다.
북미의 저분자 신약 개발 아웃소싱 시장은 2024년 세계 매출 점유율의 43.15%를 차지했습니다. 이 이점은 강력한 제약 및 생명 공학 산업, 높은 R&D 투자 및 비용 효율적인 의약품 개발의 필요성에 기인합니다.
세계 저분자 신약 개발 아웃소싱 시장에서 주요 기업으로는 Charles River Laboratories, Curia Global, Inc., Eurofins Scientific, Evotec, GenScript Biotech, Labcorp, Oncodesign, Pharmaron, Syngene, Thermo Fisher Scientific Inc., WuXi AppTec 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 저분자 신약 개발 아웃소싱 시장 인사이트
- 시장 현황
- 저분자 신약 개발 아웃소싱 시장 역학
- 성장 촉진요인과 기회
- 연구개발비 증가
- 의약품 개발의 필요성 증가
- 억제요인과 과제
- 중요한 프로세스에 대한 직접적인 제어의 상실
- 성장 촉진요인과 기회
- PESTLE 분석
- 저분자 신약 개발 아웃소싱 시장 동향
- 밸류체인 분석
제5장 세계의 저분자 신약 개발 아웃소싱 시장 : 워크플로우별
- 주요 분석 결과
- 소개
- 표적 식별 및 스크리닝
- 표적 검증 및 기능 정보 공학
- 리드 식별 및 후보 최적화
- 전임상 개발
- 기타
제6장 세계의 저분자 신약 개발 아웃소싱 시장 : 서비스별
- 주요 분석 결과
- 소개
- 화학 서비스
- 생물학 서비스
제7장 세계의 저분자 신약 개발 아웃소싱 시장 : 치료 영역별
- 주요 분석 결과
- 소개
- 호흡기계
- 통증 및 마취
- 종양
- 안과
- 혈액학
- 심혈관계
- 내분비
- 위장
- 면역조절
- 항감염성
- 중추신경계
- 피부과
- 비뇨 생식기계
제8장 세계의 저분자 신약 개발 아웃소싱 시장 : 최종 용도별
- 주요 분석 결과
- 소개
- 제약 및 바이오테크놀러지 기업
- 학술기관
제9장 세계의 저분자 신약 개발 아웃소싱 시장 : 지역별
- 주요 분석 결과
- 소개
- 저분자 신약 개발 아웃소싱 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 워크플로우별(2020-2034년)
- 북미 : 서비스별(2020-2034년)
- 북미 : 치료 영역별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 워크플로우별(2020-2034년)
- 유럽 : 서비스별(2020-2034년)
- 유럽 : 치료 영역별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 워크플로우별(2020-2034년)
- 아시아태평양 : 서비스별(2020-2034년)
- 아시아태평양 : 치료 영역별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 워크플로우별(2020-2034년)
- 중동 및 아프리카 : 서비스별(2020-2034년)
- 중동 및 아프리카 : 치료 영역별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 워크플로우별(2020-2034년)
- 라틴아메리카 : 서비스별(2020-2034년)
- 라틴아메리카 : 치료 영역별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제11장 기업 프로파일
- Charles River Laboratories
- Curia Global, Inc.
- Eurofins Scientific
- Evotec
- GenScript Biotech
- Labcorp
- Oncodesign
- Pharmaron
- Syngene
- Thermo Fisher Scientific Inc.
- WuXi AppTec
The small molecule drug discovery outsourcing market size is expected to reach USD 11.27 billion by 2034, according to a new study by Polaris Market Research. The report "Small Molecule Drug Discovery Outsourcing Market Share, Size, Trends, Industry Analysis Report By Workflow (Target Identification & Screening, Target Validation & Functional Informatics), By Service, By Therapeutics Area, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Small molecule drug discovery outsourcing refers to the practice of pharmaceutical and biotechnology companies partnering with specialized contract research organizations (CROs) to accelerate and optimize the development of small-molecule therapeutics. Small-molecule drugs, typically under 900 Daltons in molecular weight, are chemically synthesized compounds that can modulate biological targets, offering treatments for diseases ranging from cancer to metabolic disorders. Outsourcing various stages of drug discovery, such as target identification, hit-to-lead optimization, preclinical testing, and early clinical trials, allows companies to leverage external expertise, reduce costs, and accelerate timelines. CROs provide advanced technologies, high-throughput screening, computational modeling, and medicinal chemistry support, enabling faster identification of promising drug candidates.
Small molecule drug discovery outsourcing is particularly valuable for smaller biotech firms with limited infrastructure and large pharma companies seeking to streamline R&D expenses. Outsourcing also facilitates innovation by integrating diverse scientific perspectives and advanced methodologies like AI-driven drug design. The growing complexity of drug discovery, coupled with rising development costs, has made outsourcing a strategic necessity, fostering collaborations that enhance efficiency and success rates in bringing new therapies to market.
Small Molecule Drug Discovery Outsourcing Market Report Highlights
In terms of workflow, the lead identification & candidate optimization segment held 33.12% of revenue share in 2024 due to increasing R&D investments from pharmaceutical and biotechnology companies.
Based on service, the chemistry services segment dominated the revenue share in 2024 due to the critical role chemistry plays in early-stage drug development, including hit-to-lead optimization, medicinal chemistry, and lead generation.
In terms of therapeutic area, the oncology segment accounted for a major revenue share in 2024 due to the rising burden of cancer and the urgent demand for effective and targeted treatments.
The North America small molecule drug discovery outsourcing market accounted for 43.15% of global revenue share in 2024. This dominance is attributed to its strong pharmaceutical and biotech industries, high R&D investments, and the need for cost-efficient drug development.
A few global key players in the small molecule drug discovery outsourcing market include Charles River Laboratories; Curia Global, Inc.; Eurofins Scientific; Evotec; GenScript Biotech; Labcorp; Oncodesign; Pharmaron; Syngene; Thermo Fisher Scientific Inc.; and WuXi AppTec.
Polaris Market Research has segmented the small molecule drug discovery outsourcing market report on the basis of workflow, service, therapeutic area, end use, and region:
By Workflow Outlook (Revenue, USD Billion, 2020-2034)
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Others
By Service Outlook (Revenue, USD Billion, 2020-2034)
Chemistry Services
Biology Services
By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)
Respiratory System
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-infective
Central Nervous System
Dermatology
Genitourinary System
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Pharmaceutical & Biotechnology Companies
Academic Institutes
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Small Molecule Drug Discovery Outsourcing Market Insights
- 4.1. Small Molecule Drug Discovery Outsourcing Market - Market Snapshot
- 4.2. Small Molecule Drug Discovery Outsourcing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising research and development expenses
- 4.2.1.2. Increasing need for drug development
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Loss of direct control over critical processes
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Small Molecule Drug Discovery Outsourcing Market Trends
- 4.6. Value Chain Analysis
5. Global Small Molecule Drug Discovery Outsourcing Market, by Workflow
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 5.3. Target Identification & Screening
- 5.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Target Identification & Screening, by Region, 2020-2034 (USD Billion)
- 5.4. Target Validation & Functional Informatics
- 5.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2020-2034 (USD Billion)
- 5.5. Lead Identification & Candidate Optimization
- 5.5.1. Global Small Molecule Drug Discovery Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2020-2034 (USD Billion)
- 5.6. Preclinical Development
- 5.6.1. Global Small Molecule Drug Discovery Outsourcing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
- 5.7. Others
- 5.7.1. Global Small Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)
6. Global Small Molecule Drug Discovery Outsourcing Market, by Service
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 6.3. Chemistry Services
- 6.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
- 6.4. Biology Services
- 6.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Biology Services, by Region, 2020-2034 (USD Billion)
7. Global Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 7.3. Respiratory System
- 7.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Respiratory System, by Region, 2020-2034 (USD Billion)
- 7.4. Pain and Anesthesia
- 7.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Pain and Anesthesia, by Region, 2020-2034 (USD Billion)
- 7.5. Oncology
- 7.5.1. Global Small Molecule Drug Discovery Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 7.6. Ophthalmology
- 7.6.1. Global Small Molecule Drug Discovery Outsourcing Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
- 7.7. Hematology
- 7.7.1. Global Small Molecule Drug Discovery Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
- 7.8. Cardiovascular
- 7.8.1. Global Small Molecule Drug Discovery Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
- 7.9. Endocrine
- 7.9.1. Global Small Molecule Drug Discovery Outsourcing Market, by Endocrine, by Region, 2020-2034 (USD Billion)
- 7.10. Gastrointestinal
- 7.10.1. Global Small Molecule Drug Discovery Outsourcing Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
- 7.11. Immunomodulation
- 7.11.1. Global Small Molecule Drug Discovery Outsourcing Market, by Immunomodulation, by Region, 2020-2034 (USD Billion)
- 7.12. Anti-infective
- 7.12.1. Global Small Molecule Drug Discovery Outsourcing Market, by Anti-infective, by Region, 2020-2034 (USD Billion)
- 7.13. Central Nervous System
- 7.13.1. Global Small Molecule Drug Discovery Outsourcing Market, by Central Nervous System, by Region, 2020-2034 (USD Billion)
- 7.14. Dermatology
- 7.14.1. Global Small Molecule Drug Discovery Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
- 7.15. Genitourinary System
- 7.15.1. Global Small Molecule Drug Discovery Outsourcing Market, by Genitourinary System, by Region, 2020-2034 (USD Billion)
8. Global Small Molecule Drug Discovery Outsourcing Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
- 8.4. Academic Institutes
- 8.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)
9. Global Small Molecule Drug Discovery Outsourcing Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Small Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Small Molecule Drug Discovery Outsourcing Market - North America
- 9.3.1. North America: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.2. North America: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.3.3. North America: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.3.4. North America: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5. Small Molecule Drug Discovery Outsourcing Market - US
- 9.3.5.1. US: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.5.2. US: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.3.5.3. US: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.3.5.4. US: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6. Small Molecule Drug Discovery Outsourcing Market - Canada
- 9.3.6.1. Canada: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4. Small Molecule Drug Discovery Outsourcing Market - Europe
- 9.4.1. Europe: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.2. Europe: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.3. Europe: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.4. Europe: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5. Small Molecule Drug Discovery Outsourcing Market - UK
- 9.4.5.1. UK: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6. Small Molecule Drug Discovery Outsourcing Market - France
- 9.4.6.1. France: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.6.2. France: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.6.3. France: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.6.4. France: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7. Small Molecule Drug Discovery Outsourcing Market - Germany
- 9.4.7.1. Germany: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8. Small Molecule Drug Discovery Outsourcing Market - Italy
- 9.4.8.1. Italy: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9. Small Molecule Drug Discovery Outsourcing Market - Spain
- 9.4.9.1. Spain: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10. Small Molecule Drug Discovery Outsourcing Market - Netherlands
- 9.4.10.1. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11. Small Molecule Drug Discovery Outsourcing Market - Russia
- 9.4.11.1. Russia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12. Small Molecule Drug Discovery Outsourcing Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5. Small Molecule Drug Discovery Outsourcing Market - Asia Pacific
- 9.5.1. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5. Small Molecule Drug Discovery Outsourcing Market - China
- 9.5.5.1. China: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.5.2. China: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.5.3. China: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.5.4. China: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6. Small Molecule Drug Discovery Outsourcing Market - India
- 9.5.6.1. India: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.6.2. India: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.6.3. India: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.6.4. India: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7. Small Molecule Drug Discovery Outsourcing Market - Malaysia
- 9.5.7.1. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8. Small Molecule Drug Discovery Outsourcing Market - Japan
- 9.5.8.1. Japan: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9. Small Molecule Drug Discovery Outsourcing Market - Indonesia
- 9.5.9.1. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10. Small Molecule Drug Discovery Outsourcing Market - South Korea
- 9.5.10.1. South Korea: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11. Small Molecule Drug Discovery Outsourcing Market - Australia
- 9.5.11.1. Australia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12. Small Molecule Drug Discovery Outsourcing Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6. Small Molecule Drug Discovery Outsourcing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5. Small Molecule Drug Discovery Outsourcing Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6. Small Molecule Drug Discovery Outsourcing Market - UAE
- 9.6.6.1. UAE: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7. Small Molecule Drug Discovery Outsourcing Market - Israel
- 9.6.7.1. Israel: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8. Small Molecule Drug Discovery Outsourcing Market - South Africa
- 9.6.8.1. South Africa: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9. Small Molecule Drug Discovery Outsourcing Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7. Small Molecule Drug Discovery Outsourcing Market - Latin America
- 9.7.1. Latin America: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5. Small Molecule Drug Discovery Outsourcing Market - Mexico
- 9.7.5.1. Mexico: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6. Small Molecule Drug Discovery Outsourcing Market - Brazil
- 9.7.6.1. Brazil: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7. Small Molecule Drug Discovery Outsourcing Market - Argentina
- 9.7.7.1. Argentina: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8. Small Molecule Drug Discovery Outsourcing Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Charles River Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Curia Global, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Eurofins Scientific
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Evotec
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. GenScript Biotech
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Labcorp
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Oncodesign
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Pharmaron
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Syngene
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Thermo Fisher Scientific Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. WuXi AppTec
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
샘플 요청 목록